Announcement on Obtaining Australia's TGA-GMP Certificate
Filed with SSE · · 2 pages · Chinese
Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Chengyi Pharmaceutical
- Announcement on the Acquisition of Drug Registration Certificate for Calcitriol Soft Capsules
- Announcement on Progress in Repurchasing 2% of Shares through Call Auction
- Announcement on Outline of the Q3 2024 Performance Briefing
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Announcement on Obtaining Share Repurchase Loans from Financial Institutions
Later from Zhejiang Chengyi Pharmaceutical
- Announcement on the Acquisition of Drug Registration Certificate for Mercaptopurine Tablets
- Report for Q1 2025
- Announcement on Election of Employee Director for the 5th Board of Directors
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
- Announcement on Implementation of Dividend Distribution for 2024
Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Chengyi Pharmaceutical